Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

Infection and Immunity

Volumn 69, Issue 9, 2001, Pages 5565-5572

  Rogers, W O ^a   Baird, J K ^a   Kumar, A ^a   Tine, J A ^a   Weiss, W ^a   Aguiar, J C ^a   Gowda, K ^a   Gwadz, R ^a   Kumar, S ^a   Gold, M ^a   Hoffman, S L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEROZOITE ANTIGEN 1; CIRCUMSPOROZOITE PROTEIN; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PROTOZOAL PROTEIN; SPOROZOITE SURFACE PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANARYPOX VIRUS; CONTROLLED STUDY; DEVICE; DRUG ADMINISTRATION ROUTE; ERYTHROCYTE; EXPRESSION VECTOR; FEMALE; MACACA; MALARIA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PLASMODIUM KNOWLESI; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE; TREATMENT OUTCOME; VACCINATION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; AVIPOXVIRUS; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; MACACA MULATTA; MALARIA; MALARIA VACCINES; MICE; PARASITEMIA; PLASMIDS; PLASMODIUM KNOWLESI; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0034860454     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.9.5565-5572.2001     Document Type: Article

References (36)

1. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite protein 1 DNA vaccines
2. Plasmodium knowlesi: Secondary processing of the malaria merozoite surface protein-1
3. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens
4. A naturally acquired quotidian-type malaria in man transferrable to monkeys
5. Immunization of man against sporozoite-induced falciparum malaria
6. The complexity of protective immunity against liver-stage malaria
7. Circumventing genetic restriction of protection against malaria with multi-gene DNA immunization: CD8+ T cell, interferongamma, and nitric oxide dependent immunity
8. Enumeration of parasites in the blood of malarial patients
9. Lipofectin: A highly efficient, lipid-mediated DNA transfection procedure
10. Malaria DNA vaccines in Aotus monkeys
11. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: A comparison of vaccine formulation, route, and method of administration
12. Preanesthetic medication of children with midazolam using the Biojector jet injector
13. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals
14. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites
15. ELISPOT assay for detection of peptide specific interferon-secreting cells in Rhesus macaques
16. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi
17. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei
18. Structure of the Plasmodium knowlesi gene coding for the circumsporozoite protein
19. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC
20. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system
21. A highly conserved aminoacid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite
22. Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens
23. Malaria vaccines
24. Characterization of Plasmodium falciparum sporozoite surface protein 2
25. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
26. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
27. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of a malaria DNA vaccine
28. Improving protective immunity induced by DNA-based immunization: Priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus
29. Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in nonavian species
30. Cloning and cross-species comparison of the thrombospondin-related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax, and Plasmodium gallinaceum
31. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
32. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids
33. Intra-generic conservation and limited inter-strain variation in a protective minor surface antigen of Plasmodium knowlesi merozoites
34. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine
35. World malaria situation in 1992